13/05/2024  15:54:30 Chg. +0.100 Volume Bid22:00:00 Demandez à22:00:00 Capitalisation boursière Dividende Y. Rapport P/E
208.550EUR +0.05% 39
Chiffrre d'affaires: 8,169.850
206.150Bid taille: 48 207.050Ask la taille: 48 41.2 Mrd.EUR - -

Description de l'entreprise

Cencora, formerly known as AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, Cencora delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
 

Conseil d'administration & Conseil de surveillance

PDG
Steven H. Collis
Conseil d'administration
James F. Cleary, Jr., Elizabeth S. Campbell, Gina K. Clark, Kourosh Q. Pirouz, Lazarus Krikorian, Leslie E. Donato, Robert P. Mauch, Silvana Battaglia, Jennifer Dubas
Conseil de surveillance
Steven H. Collis, D. Mark Durcan, Dennis M. Nally, Henry W. McGee, Kathleen W. Hyle, Lon R. Greenberg, Ornella Barra, Richard W. Gochnauer, Redonda Miller, Lorence H. Kim, M.D.
 

Données de l'entreprise

Nom: Cencora Inc
Adresse: 1 West First Avenue,Conshohocken, PA 19428-1800, USA
Téléphone: +1-610-727-7000
Fax: +1-800-640-5221
Courriel: InvestorRelations@cencora.com
Internet: https://www.cencora.com/
Industrie: Healthcare
Secteur: Pharmaceutical Industry
Sous-secteur: Pharmaceuticals
Fin de l'exercice financier: 30/09
Flotte libre: 55.10%
IPO date: 04/04/1995

Relations avec les investisseurs

Nom: Bennett Murphy
Téléphone IR: +1-610-727-3693
IR-Fax: -
E-mail IR: bennett.murphy@cencora.com

Principaux actionnaires

Autres
 
59.68%
Vanguard Group Inc
 
10.37%
Blackrock Inc.
 
8.43%
Price (T.Rowe) Associates Inc
 
5.45%
State Street Corporation
 
3.83%
JP Morgan Chase & Company
 
3.46%
Boston Partners
 
2.46%
Geode Capital Management, LLC
 
1.73%
FMR, LLC
 
1.71%
Autres
 
2.88%